Browse studies

Find your next paid study

1 recruiting study matching your filters

ELDORADO: a Randomized Phase II Trial of Elranatamab or Daratumumab in Combination With Lenalidomide, Bortezomib, and Dexamethasone (RVd Lite) in Newly Diagnosed, Transplant Ineligible/Deferred Multiple Myeloma

This research study is being done to compare the efficacy and safety of the combination of elranatamab, lenalidomide, bortezomib, dexamethasone versus the comb…

Multiple MyelomaNewly Diagnosed Multiple MyelomaTransplant Ineligible+1 more

Massachusetts General HospitalNCT07247097